|
|
![]() ![]() ![]() |
SearchSearch results for: entered
93 results found.
10 pages of results. Sorted by relevance / Sort by date
11. Teva > News & PR
... Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which Teva will acquire Bentley. The acquisition will take ...
12. Teva News and PR
... their business relationship for controlled release generic products and active raw materials. Under agreements entered into by their respective subsidiaries, Biovail has granted Teva a four-year extension to the ...
13. Teva > News & PR
... on IMS sales data. In 2008, Teva's subsidiary Barr Pharmaceuticals, Inc. entered into a supply and licensing agreement with Bayer. Under this agreement, Teva has ...
14. Teva > News & PR
... IMS sales data. In August 2006, Teva's subsidiary Barr Pharmaceuticals, Inc. entered into a license agreement with Shire as part of a settlement of patent litigation between ...
15. Teva > News & PR
... . Food and Drug Administration (FDA), which may allow the drug to enter the market as soon as late 2011. Teva completed enrollment for the first of ...
... ) and H. Lundbeck A/S are pleased to announce that today they entered into a long term strategic alliance agreement for the co-development and marketing in Europe of ...
17. Teva > News & PR
... wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.) announced that it had entered into a supply and licensing agreement with Bayer for distribution of a generic version of ...
18. Teva > News & PR
... ® (minocycline HCl, USP) Extended Release Tablets. Pursuant to an agreement entered into between the parties, Teva has confirmed that Medicis' patents relating to SOLODYN ...
19. Teva > News & PR
... exclusivity in the U.S. Teva is distributing the product, under a license agreement entered into between Teva's subsidiary Barr Pharmaceuticals, Inc. and sanofi-aventis U.S. Allegra-D is ...
20. Teva News and PR
... Tentative Approval Of Cetirizine Hcl Tablets Jerusalem, Israel, September 13, 2004 Teva Enters Into Agreement With Schwarz Pharma to Suspend Sales of Moexipril Pending Outcome of Litigation Jerusalem ...
|